申请人:ULTRAGENYX PHARMACEUTICAL INC.
公开号:US20160289175A1
公开(公告)日:2016-10-06
The present invention provides novel creatine analogs useful for treating any creatine deficiency disorders and methods of treating and preventing creatine deficiencies utilizing the present compounds and the pharmaceutical compositions or formulations thereof. Certain embodiments seek to increase the lipophilicty of novel creatine analogs with the goal of improving their bioavailability.